OpenVSafe by OpenVAERS
Search V-safe

8G8-11207-48178

2 vaccinations 5 coded responses 21 check-ins 5 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
950 / CA
Registered
2021-01-28
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Registered in v-safe
  2. 2021-01-28
    Dose 1 — Moderna
  3. 2021-01-28
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Pre-existing condition improved — Feeling: Good
    Free text: Prior skin problems decreased? vac helped immune system
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Therapeutic response unexpected — Feeling: Good
    Free text: Beneficial to prior skin ailment, resulting in reduction in # of skin plaques on scalp
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-04
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-02-25
    Dose 2 — Moderna
  13. 2021-02-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Fatigue less than yesterday (skipped reporting)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-18
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-25
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-04-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-26
    Survey response — 6 months, dose 2
    MedDRA: Condition aggravated, Erythema multiforme, Pain, Pre-existing disease, Skin lesion, Skin plaque — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Lesions from collapsing plaques of erythema multiforme major on various parts of body, incl scalp, neck hands, wrists, elbows, shoulder blades, back, ankles, soles of feet:greatest impact: (now: right sole) lesions risk infection, minor pain · Healthcare visit (other): Did so long ago recurrence
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-26
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-12-14
  26. 2022-02-28
    Survey response — 12 months, dose 2
    MedDRA: Hidradenitis — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Hydradenitis diagnosed
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-02-28
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  28. 2022-03-03

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Moderna
22021-02-25Moderna

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-01

Systemic reaction (other): Prior skin problems decreased? vac helped immune system

2021-02-03

Systemic reaction (other): Beneficial to prior skin ailment, resulting in reduction in # of skin plaques on scalp

Release 4 — days 1–6 daily, dose 2

2021-02-27

Systemic reaction (other): Fatigue less than yesterday (skipped reporting)

Release 9 — 6 months, dose 2

2021-08-26

Symptoms: Lesions from collapsing plaques of erythema multiforme major on various parts of body, incl scalp, neck hands, wrists, elbows, shoulder blades, back, ankles, soles of feet:greatest impact: (now: right sole) lesions risk infection, minor pain
Healthcare visit (other): Did so long ago recurrence

Release 11 — 12 months, dose 2

2022-02-28

Symptoms: Hydradenitis diagnosed

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOCondition aggravated ✓ · ✓
HCVOPre-existing disease ✓ · ✓
SDErythema multiforme ✓ · ✓
SDHidradenitis · · ✓
SDPain ✓ · ✓
SDSkin lesion ✓ · ✓
SDSkin plaque ✓ · ✓
SROFatigue ✓ ✓ ✓
SROPre-existing condition improved ✓ ✓ ✓
SROTherapeutic response unexpected ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release